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Abstract
Background: Only a limited number of multiple synchronous primary malignancies of the pancreas have been
reported in the medical literature. We report a case of two solid malignant tumors of the pancreas diagnosed
preoperatively.
Case presentation: We describe a 65-year-old Sri Lankan woman who presented with progressive obstructive
jaundice. Initial contrast-enhanced computed tomography imaging detected a malignant tumor at the tail of her
pancreas. A second tumor of the pancreatic head was detected with integrated imaging using multidetector computed
tomography and multimodal magnetic resonance imaging. She underwent total pancreaticoduodenectomy and
splenectomy. Gross examination of the specimen confirmed the presence of two separate tumors. Histology of
the ampullary tumor showed pancreatic-type adenocarcinoma and the tumor in the tail of her pancreas showed
a colloid-type adenocarcinoma.
Conclusion: The possibility of multiple primary malignant solid tumors of different types with malignant potential
has to be considered even without background pathology when managing multiple tumors in the pancreas.
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Background
The finding of synchronous primary tumors involving
one organ is rare. Only a few cases of multiple solid pri-
mary pancreatic tumors have been reported in the litera-
ture [1, 2]. Most such multiple tumors were found in
previously diseased pancreases with chronic pancreatitis
[1]. We report our management experience of a pre-
operatively detected ampullary adenocarcinoma and a
mucinous pancreatic adenocarcinoma involving the tail.
Case presentation
A 65-year-old previously healthy Sri Lankan woman
was referred for the management of progressive pain-
less obstructive jaundice of 1-month duration. She
had two episodes of cholangitis which had been man-
aged with antibiotics administered intravenously.
There was loss of appetite and loss of weight (12 kg/
month). Her premorbid metabolic equivalent of task
(MET) score was >6, but was only 3 when she was
referred. She was icteric and had mild dependent
edema. Her body mass index (BMI) was 17. There
were no palpable abdominal masses.
She had biochemical evidence of obstructive jaundice:
total bilirubin 3.4 mg/dL, direct bilirubin 3.0 mg/dL, and
alkaline phosphatase (ALP) 624 IU/dL. Contrast-
enhanced computed tomography (CECT) only identified
a 26×37 mm tumor in the pancreatic tail with a mildly
dilated common bile duct (CBD) without an apparent
cause for it. Since she was unfit for major surgery an
endoscopic retrograde cholangiopancreatography (ERCP)
was performed, which demonstrated a stricture with
smooth tapering at the distal end of her CBD. The ampulla
was prominent but there was no evidence of a mass lesion
from which to take a biopsy. Brush cytology from the
stricture was negative for malignant cells. A 6 cm self-
expandable metal stent (SEMS) was inserted. Following the
endoscopic intervention, her icterus disappeared and her
liver profile improved. In order to find out the cause for* Correspondence: supun85@gmail.com
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the distal CBD stricture, a second computed tomography
(CT) scan combined with multimodal magnetic resonance
imaging (MRI) of her abdomen was performed. This com-
bined CT/MRI of her abdomen detected a second tumor
in her pancreas; it was a mass with ill-defined margins of
17×19 mm, which invaded adjacent pancreatic tissue just
inferior to the distal end of her CBD. Her superior mesen-
teric artery or vein was not involved (Fig. 1).
Her American Joint Committee on Cancer (AJCC)
stage was 2A for both tumors (ampullary tumor T3,
N0, M0 and the tumor of the tail T2, N0, M0). The
decision to offer total pancreaticoduodenectomy was
taken in a multidisciplinary team (MDT) meeting
because of the anatomical location of the two tumors.
She was referred to a nutritionist and was optimized
with supplementary parenteral nutrition for 3 weeks.
She was also vaccinated to prepare her for a possible
splenectomy. Her performance status improved within 3
weeks and a total pancreaticoduodenectomy and splenec-
tomy were performed. Her postoperative period was
complicated by a lower respiratory tract infection, superfi-
cial surgical site infection, and poor glycemic control. She
was managed in a surgical ward with the support of
endocrinology, microbiology, and nutrition teams and was
discharged on the tenth postoperative day. She was
discharged on insulin and oral penicillin for prophylaxis.
She lost 7 kg of weight postoperatively but her weight sta-
bilized after the introduction of a special dietary regimen
which included six to eight small frequent meals with
energy-dense snacks and limitation of food rich in carbo-
hydrates and fat.
A macroscopic examination of the resected specimen
revealed two distinct tumors in her pancreas. One was
an ampullary tumor measuring 30×30×28 mm. The
second tumor was found at the tail and measured
50×42×40 mm. The distance between the two tumors
was 40 mm.
An histologic examination of the ampullary tumor
(Fig. 2a) showed a moderately differentiated ampullary
adenocarcinoma of pancreaticobiliary type. This tumor
had invaded the muscularis propria of her duodenum
and the pancreatic parenchyma. Her CBD was not
infiltrated by the tumor. Vascular and perineural inva-
sion were not seen. The tumor at the pancreatic tail
(Fig. 2b) showed a moderately differentiated non-cystic
mucinous (colloid) adenocarcinoma. Perineural invasion
was seen, but vascular invasion was not detected. A few
areas of chronic pancreatitis were noted in the rest of
the pancreas but largely the morphology of the pancreas
was normal. Immunohistochemistry findings are shown
in Table 1.
She had good quality life after surgery reaching her
premorbid MET score of 6 and had a stable weight.
However, her serum albumin level was persistently low
(median 26 mg/dL). She died of severe pneumonia 8
months after surgery.
Discussion
Synchronous primary tumors of the pancreas are rare
and most of them were found in previously diseased
pancreases with chronic pancreatitis or associated
with premalignant lesions like intraductal papillary
mucinous neoplasm (IPMN). An association of IPMN
with multifocal ductal adenocarcinoma is well estab-
lished. Yamaguchi et al. reported that 20% of cases in
a series of 765 patients who underwent surgery for
IPMN had pancreatic ductal adenocarcinoma either
derived from IPMN or concomitant with IPMN [3]. Solid
pseudopapillary neoplasm too is synchronously found
with IPMN [4]. However, multifocal involvement in a
Fig. 1 Imaging of the tumours. a – Axial cut of MDCT showing the two tumors of the pancreas. The ampullary tumour (17×19 mm) with ill-
defined margins invading adjacent pancreatic tissue (white arrow) and the tumor in the tail of the pancreas (28×38 mm) with irregular margins
(red arrow). b – A coronal MRI image showing the dilated CBD with smooth tapering stricture at the distal end (white arrow) and the ampullary
tumour inferior to the distal end of CBD (red arrow)
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previously healthy pancreas has not been reported to the
best of our knowledge.
A case of two separate malignant tumors of the
pancreas was reported by Goong et al. where a tumor in
the head and another in the tail of the pancreas were
identified preoperatively [2]. Both lesions were finally
recognized as ductal adenocarcinomas by endoscopic
ultrasound-guided fine needle aspiration biopsy (EUS-
FNAB), but the histologic separation of the two tumors
could not be proven in this case as the patient had
refused surgery. Sastry et al. reported a case of three
synchronous tumors of the pancreas; an ampullary car-
cinoma with two other tumors was found incidentally in
the head and in the uncinate process, during histologic
preparation [1]. In this case, the ampullary tumor was of
a poorly differentiated adenosquamous variety whereas
the tumor in the uncinate process was a moderately
differentiated adenocarcinoma and the tumor in the
head of the pancreas was a benign neuroendocrine
tumor (NET). Evidence of background chronic pancrea-
titis was well recognized. On immunohistochemical
examination, pancreatic tumors do not have very specific
markers. Those we had access to fitted with the
morphological diagnosis; ampullary adenocarcinomas of
pancreaticobiliary type are usually cytokeratin (CK) 7+/
CK20– [5] and non-cystic mucinous (colloid) carcinoma
CK7+/CK20+ [6]. Carcinoembryonic antigen (CEA) and
epithelial membrane antigen (EMA) positivity is re-
ported in both tumors [7].
For accurate diagnosis and staging of pancreatic
neoplasms, integrated imaging is recommended. If
multidetector computed tomography (MDCT) is the
preferred imaging modality, multimodal MRI is rec-
ommended for integration in imaging for pancreatic
tumors [8]. The cause for obstructive jaundice was
not detected in the initial imaging in this case due
to the low resolution of the CECT. After ERCP con-
firmed the presence of a lower CBD stricture, CECT
combined with multimodal MRI (integrated imaging)
was able to detect the tumor at the head of her pan-
creas in addition to the previously detected tumor at
the tail.
Conclusions
The possibility of multiple primary malignant solid tu-
mors of different histological types has to be consid-
ered when managing multiple tumors in the pancreas.
This case demonstrates the importance of utilizing
optimum imaging facilities for accurate preoperative
diagnosis in order to plan the most appropriate treat-
ment option.
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Fig. 2 Histology of two tumors. a Ampullary carcinoma (hematoxylin and eosin ×200) is a moderately differentiated adenocarcinoma. b
Hematoxylin and eosin, ×200, shows an adenocarcinoma with tumor cells suspended in pools of extracellular mucin
Table 1 Immunohistochemistry of the two tumors (Dako®)
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